Sort
51,593 grants matching “hepatitis”
6B:A Pharmacokinetic & Pharmacodynamic Study of an Antibody-based Vaginal Microb
$552,301Susan Cu-Uvin · Boston University Medical Campus · U19 · FY2014 · AI
Immunoregulation in Schistosomiasis
$552,296Miguel J. Stadecker · Tufts University Boston · R01 · FY2020 · AI
Immunoregulation in Schistosomiasis
$552,296Miguel J. Stadecker · Tufts University Boston · R01 · FY2019 · AI
Immunoregulation in Schistosomiasis
$552,296Miguel J. Stadecker · Tufts University Boston · R01 · FY2018 · AI
Immunoregulation in Schistosomiasis
$552,296Miguel J. Stadecker · Tufts University Boston · R01 · FY2016 · AI
Immunoregulation in Schistosomiasis
$552,296Miguel J. Stadecker · Tufts University Boston · R01 · FY2017 · AI
Antiretroviral Therapy and the Hepatitis C Virus
$552,261Kenneth E Sherman · University Of Cincinnati · R01 · FY2010 · AI
Genetic risk factors for alcoholic cirrhosis - genome-wide case-control study
$552,182Timothy Ross Morgan · Southern California Inst For Res/Educ · U01 · FY2012 · AA
Prenatal Anxiety and its Effects on Child Development
$552,164Thomas G O'Connor · University Of Rochester · R01 · FY2008 · MH
HCV Infection--Risk Factors for Progression
$552,164Harvard University (Sch Of Public Hlth) · R01 · FY2003 · CA
Mid Southern Primary Care Networks Node
$552,141Li-Tzy T Wu · Duke University · UG1 · FY2019 · DA
Preclinical studies of a heroin/morphine vaccine for opiate addiction
$552,119Paul Pentel · Hennepin Healthcare Research Institute · R01 · FY2013 · DA
Effects of State Laws to Reduce Opioid Diversion on Transitions to Injection Drug Use and HIV/HCV Transmission
$552,095Julia B Dickson-Gomez · Medical College Of Wisconsin · R01 · FY2020 · DA
Exploring the Fetal Origins Hypothesis in Diverse Youth
$552,056Dana Dabelea · University Of Colorado Denver · R01 · FY2014 · DK
Rational development of anti-Trypanosoma cruzi drugs
$552,036Frederick Simmons Buckner · University Of Washington · R01 · FY2012 · AI
Disulfiram Interactions With HIV Medications: Clinical Implications
$551,992Elinore F. McCance-Katz · University Of California, San Francisco · R01 · FY2008 · DA
Optimizing Lung Cancer Treatment in HIV Infected Persons
$551,979Keith Magnus Sigel · Icahn School Of Medicine At Mount Sinai · R01 · FY2018 · CA
Novel therapeutic approaches to treating chronic hepatitis B virus infection
$551,970Lishan Su · Univ Of North Carolina Chapel Hill · R01 · FY2015 · DK
Bile acids and insulin sensitivity
$551,959Rebecca Anne Haeusler · Columbia University Health Sciences · R01 · FY2019 · DK
Toxic lipid intermediate accumulation and cobalamin depletion promote AHR-mediated hepatotoxicity and the progression of non-alcoholic fatty liver disease (NAFLD)-like pathologies
$551,938Timothy R Zacharewski · Michigan State University · R01 · FY2025 · ES
Life Course Investigation of People Who Inject Drugs
$551,935Robert E Booth · University Of Colorado Denver · R01 · FY2017 · DA
HCV TRANSMISSION: SEX, VIOLENCE ALCOHOL &DRUG USE
$551,910Pacific Institute For Res And Evaluation · R01 · FY2001 · DA
RECK regulation of NASH and fibrosis
$551,909Randy Scott Rector · University Of Missouri-Columbia · R01 · FY2023 · DK
RECK regulation of NASH and fibrosis
$551,909Randy Scott Rector · University Of Missouri-Columbia · R01 · FY2022 · DK
RECK regulation of NASH and fibrosis
$551,909Randy Scott Rector · University Of Missouri-Columbia · R01 · FY2025 · DK